Testing effectiveness (Phase 2)Active Not RecruitingNCT04567550
What this trial is testing
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
Who this might be right for
Diabetic Retinopathy (DR)Center-Involved Diabetic Macular Edema (CI-DME)
AbbVie 139